Sutro Biopharma Inc

NASDAQ:STRO 4:00:00 PM EDT

0.76

+0.08 (+12.35%)

7:34:23 PM EDT: $0.75 -0.01 (-1.77%)

Market Cap (Intraday)	64.53M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$15.79 Million
Adjusted EPS	-$0.41

See more estimates

10-Day MA	$0.76
50-Day MA	$0.88
200-Day MA	$1.95

See more pivots

Sutro Biopharma Inc Stock, NASDAQ:STRO

111 Oyster Point Boulevard, Suite 150, South San Francisco, California 94080

United States of America

Phone: +1.650.881.6500

Number of Employees: 338

http://www.sutrobio.com

Description

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.